Skip to main content
Equibles

UBS Group AG

Position in CATX — Perspective Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to CATX Full portfolio

Position in CATX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,517,166
-$655,006 QoQ
Shares Held
444,917
-14.6% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 130 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CATX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. CATX ranks #59 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in CATX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,517,166 444,917
2026-03-31 $2,172,172 520,905
2025-12-31 $2,547,410 926,331
2025-09-30 $2,199,119 641,143
2025-06-30 $1,282,121 372,710
2025-03-31 $1,000,072 469,518
2024-12-31 $1,823,876 571,748
2024-09-30 $1,153,253 86,386
2024-06-30 $182,469 18,302
2024-03-31 $10,182 8,557
2023-09-30 $183 680
2023-06-30 $562 841
2023-03-31 $3,201 5,002
2022-12-31 $21,074 84,298
2022-06-30 $5,411 17,458
2021-09-30 $26,759 42,476
2021-06-30 $544 680
2021-03-31 $741 680
2020-09-30 $6,786 11,702
2020-06-30 $3,279 5,858
2020-03-31 $21,991 41,495